References
Brogden RN, Heel RC, Speight TM, Avery GS. Piroxicam - a reappraisal of its pharmacology and therapeutic efficacy. Drugs 28: 292–323, 1984
Chiaini J, Wiseman EH, Lombardino JG. Excretion and metabolism of a non steroidal antiinflammatory agent, 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxinilide-1,1-dioxide, in rat, dog, monkey and man. Journal of Medicinal Chemistry 14: 1175–1177, 1971
Hobbs DC, Twomey TM. Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies. Journal of Clinical Pharmacology 19: 270–281, 1979
Nuotio P, Makisara P. Royal Society of Medicine International Congress and Symposium Series no. 1. In Brien & Wiseman (Eds), p. 25, Royal Society Medical Acad. Press, Int, London, 1978
Schiantarelli P, Acerbi D, Bovis G. Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and in man. Arzneimittel Forschung 31: 92–97, 1981
Symposium (various authors). Pharmacology, efficacy and safety of a new class of antiinflammatory agent, a review of piroxicam. American Journal of Medicine 72: 1–90, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dhaneria, S.P., Garg, S.K., Kumar, N. et al. Comparative Bioavailability Study of Two Oral Dosage Forms of Piroxicam in Healthy Indian Male Volunteers. Drug Invest 6, 300–302 (1993). https://doi.org/10.1007/BF03259604
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259604